MedTrace Logo

The FibreGum Study - Changing the Course of Obesity in Children

NCT05540678 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2026-02-18

No results posted yet for this study

Summary

The aim of this study is thus to assess the effect of a chewing gum containing fibres on body weight, metabolism and the oral and intestinal microbiomes in a population of obese children.

Conditions

  • Nutritional and Metabolic Diseases
  • Child Obesity
  • Adolescent Obesity

Interventions

DIETARY_SUPPLEMENT

FibreGum

To chew every day during a period of 6 months 3 chewing gums (morning, noon and evening) for at least 20 minutes each.

DIETARY_SUPPLEMENT

Placebo

To chew every day during a period of 6 months 3 chewing gums (morning, noon and evening) for at least 20 minutes each.

Sponsors & Collaborators

  • DCB Research AG

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Maria Luisa Balmer, Prof. med. · Department of Biomedical Research, Children Clinic Berne, Inselspital, Bern University Hospital University of Bern

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-30
Primary Completion
2026-01-23
Completion
2026-01-23

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05540678 on ClinicalTrials.gov